Gilead Sciences, Inc. (GILD) Earnings History
Annual and quarterly earnings data from 1990 to 2025
Loading earnings history...
GILD EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
GILD Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 86.7% | 40.1% | 28.9% |
| 2024 | 78.3% | 5.8% | 1.7% |
| 2023 | 76.0% | 28.0% | 20.9% |
| 2022 | 79.3% | 26.9% | 16.8% |
| 2021 | 75.8% | 36.3% | 22.8% |
Download Data
Export GILD earnings history in CSV or JSON format
Free sign-in required to download data
Gilead Sciences, Inc. (GILD) Earnings Overview
As of May 8, 2026, Gilead Sciences, Inc. (GILD) reported trailing twelve-month net income of $9.22B, reflecting +1684.2% year-over-year growth. The company earned $7.35 per diluted share over the past four quarters, with a net profit margin of 28.9%.
Looking at the long-term picture, GILD's 5-year EPS compound annual growth rate (CAGR) stands at +133.6%, indicating exceptional earnings growth. The company achieved its highest annual net income of $18.11B in fiscal 2015.
Gilead Sciences, Inc. maintains industry-leading profitability with a gross margin of 86.7%, operating margin of 40.1%, and net margin of 28.9%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including ABBV ($4.23B net income, 6.9% margin), BMY ($7.28B net income, 14.6% margin), AMGN ($7.80B net income, 21.0% margin), GILD has outperformed on profitability metrics. Compare GILD vs ABBV →
GILD Earnings vs Peers
Earnings metrics vs comparable public companies
GILD Historical Earnings Data (1990–2025)
35 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $8.51B | +1672.9% | $11.82B | $6.78 | 28.9% | 40.1% |
| 2024 | $480M | -91.5% | $1.66B | $0.38 | 1.7% | 5.8% |
| 2023 | $5.67B | +23.4% | $7.61B | $4.50 | 20.9% | 28.0% |
| 2022 | $4.59B | -26.2% | $7.33B | $3.64 | 16.8% | 26.9% |
| 2021 | $6.22B | +4961.0% | $9.92B | $4.93 | 22.8% | 36.3% |
| 2020 | $123M | -97.7% | $4.07B | $0.10 | 0.5% | 16.5% |
| 2019 | $5.39B | -1.3% | $4.29B | $4.22 | 24.0% | 19.1% |
| 2018 | $5.46B | +17.9% | $8.20B | $4.17 | 24.7% | 37.1% |
| 2017 | $4.63B | -65.7% | $14.12B | $3.51 | 17.7% | 54.1% |
| 2016 | $13.50B | -25.4% | $17.63B | $9.94 | 44.4% | 58.0% |
Full GILD Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Should I Buy GILD Right Now?
Bull case, key risks, Wall St analyst verdict, and what council investors are saying — updated daily.
See GILD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GILD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GILD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonGILD — Frequently Asked Questions
Quick answers to the most common questions about buying GILD stock.
Is GILD growing earnings?
GILD EPS is $7.35, with earnings growth accelerating to +1684.2%. This exceeds the 5-year CAGR of +133.6%. TTM net income reached $9.2B.
What are GILD's profit margins?
Gilead Sciences, Inc. net margin is +28.9%, with operating margin at +40.1%. Above-average margins indicate pricing power.
How consistent are GILD's earnings?
GILD earnings data spans 1990-2025. The accelerating earnings trend is +1684.2% YoY. Historical data enables comparison across business cycles.